2 June 2026
Company News
Healthcare | Laboratories | Bio Medical Research
SteelcoBelimed and In Vitro Technologies are pleased to announce the next phase of their long-standing collaboration across Australia and New Zealand.
Following the creation of the SteelcoBelimed Joint Venture between Steelco and Belimed, In Vitro Technologies has been appointed as the exclusive distributor for Steelco and Belimed equipment across the Australian and New Zealand markets, effective 1 January 2027.
This strategic partnership further strengthens SteelcoBelimed’s commitment to delivering advanced cleaning, disinfection and sterilization workflow solutions supported by strong local expertise, responsive service and long-term customer support throughout the ANZ region.
Drawing on more than 50 years of specialised experience in Sales, Service and Education, In Vitro Technologies has been a trusted Steelco partner since 2004 and will continue supporting customers through the SteelcoBelimed transition and beyond.
Established in 2002 and backed by the multi-generational Australian family company JJ Richards & Sons Pty Ltd, In Vitro Technologies has developed into one of the leading scientific and medical distribution organisations across Australia and New Zealand, with dedicated local teams supporting Healthcare, Laboratories and Bio Medical Research markets nationwide.
In Vitro Technologies will represent Steelco and Belimed advanced cleaning and sterilization solutions for Healthcare, Laboratories and Bio Medical Research (BMR) applications throughout Australia and New Zealand.
The collaboration combines SteelcoBelimed’s global innovation and manufacturing expertise with In Vitro Technologies’ strong local presence, technical capabilities and customer-focused support organisation. Together, the companies will continue providing compliant turnkey solutions, project coordination, installation, technical service, education and after-sales support across the ANZ market.
This partnership ensures customers will continue benefiting from:
SteelcoBelimed and In Vitro Technologies remain fully committed to supporting customers throughout the transition period and look forward to continuing to build a strong and sustainable partnership across Australia and New Zealand.